Research progress of circulating free DNA in breast cancer / 中国综合临床
Clinical Medicine of China
;
(12): 229-231, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-884169
ABSTRACT
Liquid biopsy of circulating free DNA has become an auxiliary method to evaluate cancer.Because of the advantages of minimally invasive and simple, it plays an increasingly important role in the screening, diagnosis, monitoring treatment, prognosis and drug resistance detection of breast cancer.This article reviews the clinical application and related research progress of circulating free DNA (cfdna) in breast cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Clinical Medicine of China
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS